SHELL ASSET MANAGEMENT CO - ENANTA PHARMACEUTICALS INC ownership

ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 155 filers reported holding ENANTA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 2.37 and the average weighting 0.1%.

Quarter-by-quarter ownership
SHELL ASSET MANAGEMENT CO ownership history of ENANTA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$53
-49.0%
4,784
-1.5%
0.00%
-50.0%
Q2 2023$104
-47.5%
4,859
-0.6%
0.00%
-50.0%
Q1 2023$198
-13.2%
4,887
-0.3%
0.01%
-20.0%
Q4 2022$228
-99.9%
4,904
-17.4%
0.01%
-16.7%
Q3 2022$308,000
-13.0%
5,939
-20.7%
0.01%
+20.0%
Q2 2022$354,000
-33.5%
7,486
+0.2%
0.01%
-23.1%
Q1 2022$532,000
-17.0%
7,469
-12.9%
0.01%0.0%
Q4 2021$641,000
+32.2%
8,573
+0.3%
0.01%
+18.2%
Q3 2021$485,000
+23.7%
8,544
-4.2%
0.01%
+37.5%
Q2 2021$392,000
-5.8%
8,914
+5.7%
0.01%0.0%
Q1 2021$416,000
+143.3%
8,434
+107.4%
0.01%
+100.0%
Q4 2020$171,000
-8.1%
4,0660.0%0.00%0.0%
Q3 2020$186,000
+14.1%
4,066
+25.5%
0.00%0.0%
Q2 2020$163,000
-1.8%
3,241
+0.3%
0.00%
-20.0%
Q1 2020$166,000
-18.2%
3,232
-1.5%
0.01%
+25.0%
Q4 2019$203,000
-1.0%
3,282
-3.6%
0.00%
-20.0%
Q3 2019$205,000
-29.3%
3,405
-0.8%
0.01%
-16.7%
Q2 2019$290,000
-49.9%
3,434
-43.4%
0.01%
-53.8%
Q1 2019$579,000
+34.7%
6,0650.0%0.01%
+18.2%
Q4 2018$430,000
-23.4%
6,065
-7.6%
0.01%0.0%
Q3 2018$561,0006,5650.01%
Q1 2017$0
-100.0%
0
-100.0%
0.00%
-100.0%
Q4 2016$534,00015,9460.01%
Other shareholders
ENANTA PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Krensavage Asset Management, LLC 511,186$43,686,00011.23%
GREAT POINT PARTNERS LLC 210,400$17,981,0002.80%
ARMISTICE CAPITAL, LLC 456,000$38,970,0002.34%
Matarin Capital Management, LLC 210,208$17,964,376,0001.16%
Sapphire Star Partners LP 8,168$698,0000.70%
Granahan Investment Management 103,320$8,830,0000.48%
FARALLON CAPITAL MANAGEMENT LLC 867,500$74,137,0000.44%
361 CAPITAL LLC 19,040$1,627,0000.35%
ALGERT GLOBAL LLC 17,922$1,532,0000.33%
AlphaMark Advisors, LLC 9,310$796,0000.32%
View complete list of ENANTA PHARMACEUTICALS INC shareholders